AK Medical Holdings Limited disclosed a Next Day Disclosure Return indicating the on-market repurchase of 50,000 ordinary shares on 12 October 2026 at a single price of HKD 4.585 per share. The transaction cost HKD 0.23 million, funded entirely from the company’s internal resources.

Following the buyback, the company’s issued share capital (excluding treasury shares) fell 0.0047% to 1.07682 billion shares, while treasury shares increased to 33.16 million. Total issued shares, inclusive of treasury holdings, remained unchanged at 1.10998 billion.

The repurchase forms part of the mandate approved by shareholders on 17 June 2026, which authorizes the company to buy back up to 112.46 million shares. Cumulative repurchases under this mandate now stand at 48.73 million shares, equivalent to 4.33% of the issued share base on the mandate date. In accordance with Hong Kong Stock Exchange rules, AK Medical is subject to a moratorium on issuing new shares or transferring treasury shares until 11 November 2026.